CHICAGO--(BUSINESS WIRE)--Mar 12, 2019--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that its shares have been approved for immediate listing on the OTCQX® Best Market, the top tier of the three markets for the over-the-counter trading of stocks. Cresco Labs’ stock, which started being quoted on the OTC on March 6, 2019, will continue to trade under the symbol “CRLBF”.
The OTCQX Best Market is for established, investor-focused U.S. and international companies. To qualify for the OTCQX market, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, be current in their disclosure, and have a professional third-party sponsor introduction. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.
“Being upgraded to the OTCQX Best Market represents another important milestone for Cresco Labs and reflects our commitment to adhering to high standards of compliance, disclosure and corporate governance,” said Cresco Labs CEO and Co-founder Charlie Bachtell. “We believe that listing on the OTCQX will open up our stock to a larger universe of potential investors. With increased liquidity and better exposure to U.S. investors, we believe the move to the OTCQX will be beneficial to both new and existing shareholders.”
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Cresco Labs on www.otcmarkets.com.
Cresco Labs will also continue to trade on the Canadian Securities Exchange (“CSE”) under the ticker symbol "CL".
Investors, media and other interested parties are invited to visit Cresco’s Investors website at investors.crescolabs.com to view company information and request automated email alerts for future news and public filings.
About Cresco Labs:
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a cutting-edge brand strategy spearheaded by several of the brightest minds in consumer marketing in the nation. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the company’s CSE Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190312005089/en/
Jason Erkes, Cresco Labs
Chief Communications Officer
Aaron Miles, Cresco Labs
Vice President, Investor Relations
firstname.lastname@example.orgFor general Cresco Labs inquiries:
KEYWORD: UNITED STATES NORTH AMERICA CANADA ILLINOIS
INDUSTRY KEYWORD: HEALTH ALTERNATIVE MEDICINE RETAIL SPECIALTY TOBACCO OTHER RETAIL
SOURCE: Cresco Labs
Copyright Business Wire 2019.
PUB: 03/12/2019 07:30 AM/DISC: 03/12/2019 07:30 AM